Immunotherapy Cost

Success Rate 99% Success Rate

2 weeks Recovery Time

5 days Hospital Stay

Surgical Treatment Type

Your health, our priority – We offer you the finest treatment with personalized care that goes beyond treatment. Reach out to us today.

Immunotherapy is revolutionizing cancer treatment by empowering the body’s immune system to recognize and destroy cancer cells. For many advanced or resistant cancers—including lung, bladder, melanoma, kidney, lymphoma, and leukemia—immunotherapy offers not just extended survival, but sometimes lasting remission.

India has emerged as a destination of choice—offering globally recognized immunotherapies at a fraction of Western prices, supported by top-tier hospitals and leading oncologists. This comprehensive guide covers everything you need to know about immunotherapy costs, therapy types, success rates, and why patients from around the world choose India for treatment.

Understanding Immunotherapy and Its Variants

Immunotherapy refers to a range of treatments that boost or guide the immune system to target cancer cells effectively. Major classes include:

Checkpoint inhibitors (e.g. nivolumab, pembrolizumab, atezolizumab)
Monoclonal antibodies targeting tumor-specific antigens
CAR T‑cell therapy (engineered T‑cells directed at cancer targets)
Cancer vaccines designed to stimulate immune response
Cytokines and immunomodulators that enhance immune activity
Adoptive cell transfer and other personalized cell therapies

India now offers all of these modalities, often under expert care and at significantly lower costs compared to western countries.

How Immunotherapy Works

These therapies work by:

Blocking tumor-mediated immune suppression (via PD‑1/PD‑L1 or CTLA‑4 pathways)
Genetically reprogramming a patient’s T-cells to attack cancer
Enhancing immune cell proliferation or function with cytokines or drugs
Training the body to recognize cancer-specific antigens

Such treatments can lead to durable responses—even in metastatic disease—especially when guided by biomarkers like PD-L1 expression or mismatch repair status.

Why Choose India for Cancer Immunotherapy

Substantial cost advantage over Western countries
Modern treatment protocols and global-standard care
Shorter waiting times, especially for urgent or advanced cases
Multilingual support and medical tourism facilitators for international patients
High-quality clinical infrastructure–PET-CT, in‑house labs, molecular diagnostics, clinical trial access
Compassionate care models, especially in public institutions with subsidized pricing

Planning Your Immunotherapy Journey

Pre-treatment Requirements:

Biopsy confirmation and genomic profiling (e.g. PD-L1, TMB, MSI)
PET‑CT/MRI/CT scans to stage disease
Baseline blood tests and organ function evaluation
Second opinion if needed

Treatment Scheduling:

Most immunotherapy drugs are administered via IV infusion in daycare/OPD settings
Patients need medical footing for side-effect monitoring
Session frequency varies: weekly, every 2-week, monthly depending on drug

Monitoring & Follow‑Up:

Periodic imaging (CT, PET) to assess response
Regular blood tests to monitor organ function and immune-related effects
Allergy or immune‑mediated adverse events managed through dexamethasone, antihistamines

Emotional & Financial Preparation:

Emotional counseling and support for side effects or uncertainty
Financial counseling to plan cycles, drug availability, and subsidies
Engage with patient support groups or hospital social workers

Conclusion

Immunotherapy represents a transformative advancement in cancer treatment offering durable responses with fewer side effects. India delivers this cutting-edge care at significantly lower costs—with access to CAR‑T therapies, checkpoint inhibitors, vaccines, and personalized cell therapies. Top hospitals, global-quality diagnostics, and compassionate care models combine to make India a compelling choice for international patients seeking world-class cancer care on a budget.

India offers not just affordable pricing, but also state-of-the-art protocols, clinical trial access, and continuous patient support. Whether you’re exploring options in checkpoint therapy or advanced CAR‑T cell treatment, India provides therapeutic hope, emerging success, and a healing environment.

Top Hospitals for Immunotherapy Cost

Below are the list of the top hospitals that are known for Immunotherapy Cost procedures:

Gleneagles Global Hospital Parel Mumbai

Established in: 1996

Established in: 1988

Number of Beds: 550

Super Specialty

Location: Hyderabad

Book Appointment

Hisar Intercontinental Hospital

Established in: 2006

Number of Beds: 170

Multi Specialty

Location: Istanbul, Turkey

Book Appointment

Fortis Memorial Research Institute, Gurgaon

Established in: 2001

Number of Beds: 310

Multi Speciality

Location: Gurgaon

Book Appointment

Continental Hospitals Hyderabad

Established in: 2013

Number of Beds: 750

Super Specialty

Location: Hyderabad

Book Appointment

Our Services

Transparent • Professional • Without Hassles

Compare Cost Estimates

Get detailed cost breakdowns and compare prices across multiple hospitals

Book Doctor Appointment

Schedule appointments with top specialists at your convenience

Hospitalisation Support

Complete assistance from admission to discharge with dedicated care

Video Consultation

Consult doctors online or in-person based on your preference

Travel Assistance

Visa support, flight booking, and airport pickup services

Language Interpreter

Multilingual support to ensure clear communication

Accommodation

Comfortable stay arrangements near the hospital

24/7 Support

Round-the-clock assistance for all your medical needs

Top Immunotherapy Cost Specialists

Cancer Care / Oncology, Bone Marrow Transplant, Hematology Oncology, Haematology (Hematology) View Profile

4.0

Experience: 33 Years of Experience

Education: Director , MBBS, MS

Get a free consultancy

Book Appointment Chat on WhatsApp

Surgical Oncologist View Profile

Dr. Biswajyoti Hazarika

Gurgaon

4.0

Experience: 20

Education: MBBS , MS , Fellowship

Get a free consultancy

Book Appointment Chat on WhatsApp

Medical Oncologist View Profile

Dr. Rakesh Chopra

4.0

Experience: 15 years of experience

Education: HOD , MBBS, MD

Get a free consultancy

Book Appointment Chat on WhatsApp

Medical Oncologist View Profile

Dr. Vinod Raina

Gurugram

4.0

Experience: 50

Education: MBBS, MD, MRCP, FRCP

Get a free consultancy

Book Appointment Chat on WhatsApp

Get Free Consultation

Fill out the form below and our team will get back to you shortly

Treatment Costs in India

Factors Influencing Cost in India

Treatment costs in India vary depending on several major factors:

Type of immunotherapy drug (e.g. checkpoint inhibitor vs CAR‑T cell)
Brand name vs biosimilar or Indian generic
Frequency and total number of cycles
Cancer type and stage (solid tumor vs hematologic malignancy)
Diagnostic tests and biomarker profiling (e.g. PD‑L1, MSI, TMB)
Hospital choice (private multispecialty, government institute, JCI/NABH accreditation)
City or region (metro cities may charge more)
Supportive medications, imaging, follow-up care
Daycare vs inpatient setting depending on complications

How Much Does Immunotherapy Cost in India?

Single-Cycle Cost Estimates

Per cycle cost range in India:

Checkpoint inhibitors: ₹80,000 – ₹150,000 (approx. $1,000–2,000)
Monoclonal antibodies / targeted antibodies: ₹150,000 – ₹400,000
Cancer vaccines or cytokines: ₹50,000 – ₹200,000
Adoptive cell therapy (non‑CAR‑T): ₹300,000 – ₹700,000
CAR T‑cell therapy (e.g. NexCAR19 in India): ₹30,00,000 – ₹60,00,000+
Immunomodulators: ₹100,000 – ₹300,000 per cycle

Full Treatment Course (Multi-cycle)

Patients often require 4 to 12 cycles, depending on response and protocol. Total cost for a full course:

Lower-end immunotherapy courses: ₹3,00,000 – ₹8,00,000
Comprehensive checkpoint regimens (e.g., pembrolizumab/nivolumab): ₹10,00,000 – ₹45,00,000

CAR‑T Cell therapy course: ₹30,00,000 – ₹60,00,000+ depending on hospital and consumables

Breaking Down Additional Costs

Aside from drug charges, other expenses include:

Consultation & oncology evaluations: ₹500 – ₹5,000 per visit
Pre‑treatment scans (PET‑CT, MRI, CT): ₹5,000 – ₹40,000
Diagnostic biopsy and blood tests: ₹1,000 – ₹30,000
PD‑L1, MSI, TMB and genomic profiling: Usually ₹20,000–50,000+
Support medications (steroids, anti-inflammatories): Variable, depending on side‑effects
Daycare facility charges or brief hospitalization

Even factoring these in, the total cost is typically far lower than Western countries.

Frequently Asked Questions

FAQs

Who is eligible for immunotherapy?
Patients with advanced or refractory cancers where targetable biomarkers (PD-L1, MSI, etc.) are positive; defined cancer types (melanoma, lung, bladder, lymphoma).
What is the typical success rate?
Approximately 15–20% of patients achieve durable remission with checkpoint inhibitors; CAR T-cell therapy offers higher remission in eligible blood cancers (> 50% long-term in many centers)
Are generics or biosimilars available?
Some biosimilars of pembrolizumab or nivolumab are being developed locally, offering reduced cost—though many hospitals still use branded drugs.
Can insurance cover immunotherapy?
Increasingly yes; national schemes and private insurers cover drugs if approved. Pharma patient‑support programs also assist. Check your policy details.
What are common side effects?
Mild flu-like symptoms, fatigue, rashes, organ inflammation (colitis, pneumonitis), endocrine dysfunction, blood count changes.
Can international patients access treatment easily?
Yes—major hospitals offer medical visa support, transport coordination, interpreter services, and personalized case managers.
Is CAR T‑cell therapy available in India?
Yes. Institutions like Tata Memorial and private hospitals offer CAR‑T therapy like NexCAR19 at ₹30–40 lakh, much lower than international cost (~₹3–4 crore).
Are there affordable options for low-income patients?
Yes—government hospitals and charitable centres (Kidwai, Tata Memorial, RCC Thiruvananthapuram) offer subsidized or free treatment.

9. Are there any side effects of immunotherapy?

Yes, while immunotherapy is generally well-tolerated compared to chemotherapy, some patients may experience side effects such as:

Fatigue
Skin rash or itching
Flu-like symptoms
Inflammation in organs (lungs, liver, or intestines)
Autoimmune reactions in rare cases
These side effects are usually manageable with medications or by adjusting the therapy.

10. How long does immunotherapy treatment last in India?

The duration of immunotherapy varies depending on your cancer type, treatment response, and tolerance. In many cases, treatment is given every 2 to 3 weeks over a course of 6 months to 2 years. Some patients may require long-term maintenance therapy if they continue to respond well.

11. Can international patients get immunotherapy treatment in India?

Absolutely. India is a leading medical tourism destination for cancer care, including immunotherapy. Top hospitals in cities like Delhi, Mumbai, Chennai, and Bengaluru offer world-class immunotherapy protocols at much lower costs compared to the US, UK, or Europe. International patients are provided with visa support, airport pick-up, multilingual coordinators, and post-treatment care assistance.